WASHINGTON, April 21, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2022. For the quarter ended April 1, 2022, net earnings were $1.7 billion, or $2.31 per diluted common share which represents a 1.0% increase over the comparable 2021 period. Non-GAAP adjusted diluted net earnings per common... Read more
Part of Ongoing Commitment to Build a More Sustainable and Equitable Future RYE BROOK, N.Y.–(BUSINESS WIRE)–Apr. 19, 2022– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today an initial commitment to invest $5 million of its on-hand capital in mission-driven financial institutions that... Read more
Leading developer of assays for T cell measurement introduces Certimmune global immunology services to support vaccine manufacturers in their phased clinical trials WHAT: Oxford Immunotec, a PerkinElmer company, will exhibit at the World Vaccine Congress in Washington D.C. from April 18-21. This live, in-person event is the largest, most established meeting covering the entire vaccine... Read more
Danaher Announces Conversion Date For Series A Mandatory Convertible Preferred Stock WASHINGTON, April 12, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its 4.75% Series A Mandatory Convertible Preferred Stock (the “Preferred Stock”), will automatically convert into shares of the Company’s Common Stock on April 15, 2022 (the “Conversion Date”). The conversion rate... Read more
Innovative solutions offer researchers flexible therapeutic tools to deepen understanding of cancer’s biology to enable advances in immunotherapy, targeted treatments, and personalized medicine WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, will be at The American Association for Cancer Research (AACR) Annual Meeting from April 8-13 in New Orleans (booths... Read more
Launches first-of-its-kind automated ultrasound platform to accelerate preclinical research WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 7, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the expansion of its in vivo imaging portfolio with the launch of the Vega® imaging system, a first-of-its kind ultrasound platform that combines hands-free, automated... Read more
MENLO PARK, Calif., April 04, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, announced today a new collaboration with global agriculture company, Corteva Agriscience, to develop custom, end-to-end workflows for plant, pest and microbial sequencing. The project focuses on establishing high-throughput workflows in DNA extraction and library... Read more
New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 4, 2022– PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced two ready-to-use HTRF® and AlphaLISA® no-wash assay kits designed to quickly and easily detect and quantify CHO HCP impurities during... Read more
WASHINGTON, March 21, 2022 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2022 on Thursday, April 21, 2022 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section of... Read more
AFNOR validated, immunoassay addition accelerates results, lowers cost per sample and ease of use WHAT: PerkinElmer, Inc. a global leader committed to innovating for a healthier world, today launched a pet food testing extension to its Solus One™ Salmonella test kit, a leading, highly efficient immunoassay for the detection of Salmonella in food and environmental... Read more